Replies to post #2049 on AIM ImmunoTech Inc (AIM)

[mick]

Aug-18-22 09:05AM
AIM ImmunoTech Announces Commencement of Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer
GlobeNewswire
Aug-16-22 04:05PM
AIM Stockholder Full Value Committee Reiterates Intent to Proceed with Nominations and Proxy Solicitation
GlobeNewswire
-5.50%
Aug-15-22 04:05PM
AIM ImmunoTech Provides Update on Jorgl Activist Group Litigation
Business Wire
08:05AM
AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update
GlobeNewswire

[BooDog]

This is the AIM I see...

AIM
Bid: 0.70 Ask: 0.7089 Last: 0.7001 Chg ($): -0.0025 Vol: 20.03K
https://finviz.com/quote.ashx?t=AIM